Nicolas Jonckheere

2.4k total citations
55 papers, 1.8k citations indexed

About

Nicolas Jonckheere is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Nicolas Jonckheere has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Oncology and 12 papers in Surgery. Recurrent topics in Nicolas Jonckheere's work include Glycosylation and Glycoproteins Research (30 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Galectins and Cancer Biology (9 papers). Nicolas Jonckheere is often cited by papers focused on Glycosylation and Glycoproteins Research (30 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Galectins and Cancer Biology (9 papers). Nicolas Jonckheere collaborates with scholars based in France, United States and Netherlands. Nicolas Jonckheere's co-authors include Isabelle Van Seuningen, Nicolas Skrypek, Emmanuelle Leteurtre, Bélinda Duchêne, Audrey Vincent, Marie‐Paule Ducourouble, Pascal Pigny, Bernadette Neve, C. Mariette and Mohamed Hebbar and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Nicolas Jonckheere

53 papers receiving 1.8k citations

Peers

Countries citing papers authored by Nicolas Jonckheere

Since Specialization

Citations

This map shows the geographic impact of Nicolas Jonckheere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Jonckheere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Jonckheere more than expected).

Fields of papers citing papers by Nicolas Jonckheere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Jonckheere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Jonckheere. The network helps show where Nicolas Jonckheere may publish in the future.

Co-authorship network of co-authors of Nicolas Jonckheere

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Jonckheere. A scholar is included among the top collaborators of Nicolas Jonckheere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Jonckheere. Nicolas Jonckheere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of metabolite biomarkers for pancreatic neuroendocrine tumours using a metabolomic approach 2025 ·European Journal of Endocrinology ·Arnaud Jannin, Sophie Dabo‐Niang, Christine Do Cao, Amandine Descat, Stéphanie Espiard, Catherine Cardot-Bauters, Marie‐Christine Vantyghem, Benjamin Chevalier, (unknown), (unknown), (unknown), Sophie Dominguez, (unknown), François Pattou, Camille Marciniak, (unknown), Isabelle Van Seuningen, Nicolas Jonckheere, Anne‐Frédérique Dessein, Lucie Coppin	0
2	The kinase domain of TRPM7 interacts with PAK1 and regulates pancreatic cancer cell epithelial-to-mesenchymal transition 2025 ·Cell Death and Disease ·(unknown), Bernadette Neve, (unknown), (unknown), (unknown), Mouloud Souidi, Sylvie Brassart‐Pasco, Frédéric Hague, Stéphanie Guénin, Bélinda Duchêne, Laurent Gutierrez, Olivier Destaing, Isabelle Dhennin‐Duthille, Isabelle Van Seuningen, Nicolas Jonckheere, Mathieu Gautier	1
3	A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice 2023 ·Frontiers in Immunology ·(unknown), Rami Mustapha, Bélinda Duchêne, Kumar Abhishek, Elisabeth Werkmeister, Emmanuelle Leteurtre, Olivier Moralès, Nicolas Jonckheere, Isabelle Van Seuningen, Nadira Delhem	6
4	Metabolism of pancreatic neuroendocrine tumors: what can omics tell us? 2023 ·Frontiers in Endocrinology ·Arnaud Jannin, Anne‐Frédérique Dessein, Christine Do Cao, Marie‐Christine Vantyghem, Benjamin Chevalier, Isabelle Van Seuningen, Nicolas Jonckheere, Lucie Coppin	7
5	TRPM7 Modulates Human Pancreatic Stellate Cell Activation 2022 ·Cells ·(unknown), Philippe Kischel, (unknown), Nicolas Jonckheere, (unknown), Stéphanie Guénin, (unknown), Isabelle Van Seuningen, Halima Ouadid‐Ahidouch, Hemant M. Kocher, Isabelle Dhennin‐Duthille, Mathieu Gautier	9
6	Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma 2021 ·Cancers ·(unknown), Mouloud Souidi, (unknown), Bélinda Duchêne, Bernadette Neve, Lucie Coppin, Emmanuelle Leteurtre, Jérôme Torrisani, Isabelle Van Seuningen, Nicolas Jonckheere	7
7	Unsupervised Hierarchical Clustering of Pancreatic Adenocarcinoma Dataset from TCGA Defines a Mucin Expression Profile that Impacts Overall Survival 2020 ·Cancers ·Nicolas Jonckheere, (unknown), (unknown), Lucie Coppin, (unknown), Audrey Vincent, Bernadette Neve, Mathieu Gautier, Víctor Treviño, Isabelle Van Seuningen	17
8	EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway? 2020 ·Journal of Medicinal Chemistry ·(unknown), Nicolas Jonckheere, Patricia Melnyk, Isabelle Van Seuningen, Nicolas Lebègue	12
9	TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727 2018 ·Cancers ·V Drubay, Nicolas Skrypek, (unknown), (unknown), Céline Schulz, (unknown), Bélinda Duchêne, Lucie Coppin, Isabelle Van Seuningen, Nicolas Jonckheere	19
10	Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), (unknown), Yannick Delpu, Florence Renaud, Emmanuelle Leteurtre, Jérôme Torrisani, Nicolas Jonckheere, Isabelle Van Seuningen	97
11	Targeting MUC4 in pancreatic cancer: miRNAs 2015 ·Oncoscience ·Nicolas Jonckheere, (unknown), Isabelle Van Seuningen	7
12	miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer 2014 ·Oncogene ·(unknown), Yannick Delpu, Audrey Vincent, Florence Renaud, Mathieu Messager, Bélinda Duchêne, Emmanuelle Leteurtre, (unknown), Jérôme Torrisani, Nicolas Jonckheere, Isabelle Van Seuningen	57
13	The MUC1 mucin regulates the tumorigenic properties of human esophageal adenocarcinomatous cells 2014 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Caroline Gronnier, (unknown), (unknown), Nicolas Jonckheere, Michaël Perrais, Emmanuelle Leteurtre, Guillaume Piessen, C. Mariette, Isabelle Van Seuningen	16
14	Helicobacter pylori urease and flagellin alter mucin gene expression in human gastric cancer cells 2013 ·Gastric Cancer ·Michaël Perrais, Christel Rousseaux, Marie‐Paule Ducourouble, René Courcol, Pascal Vincent, Nicolas Jonckheere, Isabelle Van Seuningen	35
15	GATA-4/-6 and HNF-1/-4 families of transcription factors control the transcriptional regulation of the murine Muc5ac mucin during stomach development and in epithelial cancer cells 2012 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Nicolas Jonckheere, Audrey Vincent, (unknown), Janneke Witte‐Bouma, (unknown), Emmanuelle Leteurtre, Ingrid B. Renes, Isabelle Van Seuningen	14
16	Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression 2009 ·British Journal of Cancer ·Nicolas Jonckheere, (unknown), Laurence Stechly, Nathalie Saint‐Laurent, Sébastien Aubert, Christiane Susini, Guillemette Huet, Nicole Porchet, Isabelle Van Seuningen, Pascal Pigny	34
17	Analysis of mPygo2 mutant mice suggests a requirement for mesenchymal Wnt signaling in pancreatic growth and differentiation 2008 ·Developmental Biology ·Nicolas Jonckheere, Erin Mayes, Hung-Ping Shih, Boan Li, Oleg Lioubinski, Xing Dai, Maike Sander	19
18	Cell-specific transcriptional regulation of human mucin gene MUC4 by HNF-1/-3/-4, Cdx-1/-2, and GATA-4 transcription factors involved in the development of the gut endoderm 2008 ·Nicolas Jonckheere, Pascal Pigny, Brigitte Hémon, (unknown), Michaël Perrais, JP Aubert, Isabelle Van Seuningen	0
19	The Membrane-Bound Mucins: How Large O-Glycoproteins Play Key Roles in Epithelial Cancers and Hold Promise as Biological Tools for Gene-Based and Immunotherapies 2008 ·Critical Reviews™ in Oncogenesis ·Nicolas Jonckheere, Isabelle Van Seuningen	43
20	The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells 2005 ·Biochemical Journal ·(unknown), Michaël Perrais, (unknown), Nicolas Jonckheere, Marie‐Paule Ducourouble, Jean‐Pierre Aubert, Pascal Pigny, Isabelle Van Seuningen	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact